Table 1 The top 10 NCDs in the full sample (n = 8602) ordered by % (overall and after completion of phase 2 questionnaire)
Rank | Events overall (n = 8602) | n | Weighted % (95% CI) | New events after phase 2 (n differs by condition)a | n | Weighted % (95% CI) |
|---|---|---|---|---|---|---|
1 | Gastrointestinal Disorders | 482 | 5.62 (5.04, 6.19) | Gastrointestinal Disorders | 303/8423 | 3.64 (3.17, 4.12) |
2 | Other Joint Disorders | 467 | 5.60 (5.02, 6.18) | Other Joint Disorders | 291/8426 | 3.38 (2.93, 3.83) |
3 | Arthritis/osteoarthritis | 183 | 2.18 (1.82, 2.55) | Arthritis/osteoarthritis | 131/8550 | 1.54 (1.23, 1.85) |
4 | Hypertension | 151 | 2.02 (1.66, 2.37) | Hypertension | 105/8556 | 1.38 (1.09, 1.68) |
5 | Prostate and other genitourinary disorder | 158 | 1.94 (1.59, 2.29) | Prostate and other genitourinary disorder | 90/8534 | 1.14 (0.87, 1.41) |
6 | Asthma/COPD | 130 | 1.59 (1.27, 1.91) | Asthma/COPD | 88/8560 | 1.01 (0.76, 1.26) |
7 | Back and neck pain | 123 | 1.56 (1.25, 1.88) | Back and neck pain | 76/8555 | 0.92 (0.68, 1.16) |
8 | Cancer and Tumours | 99 | 1.30 (1.01, 1.59) | Cancer and Tumours | 67/8570 | 0.89 (0.65, 1.14) |
9 | Migraine/headache | 88 | 1.00 (0.75, 1.25) | Hyperlipidaemia | 55/8589 | 0.72 (0.51, 0.94) |
10 | Hyperlipidaemia | 68 | 0.90 (0.66, 1.14) | Migraine/headache | 53/8567 | 0.68 (0.47, 0.89) |